Healthcare provider profile · identity verified

Yan Lin He, D.O.

Internal Medicine · LONGVIEW, WA · NPI 1538470331

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	918	269
Lisinopril	Lisinopril	622	182
Amlodipine Besylate	Amlodipine Besylate	494	153
Losartan Potassium	Losartan Potassium	490	161
Levothyroxine Sodium	Levothyroxine Sodium	477	129
Metoprolol Tartrate	Metoprolol Tartrate	396	112
Simvastatin	Simvastatin	372	104
Gabapentin	Gabapentin	341	97
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	322	46
Metformin Hcl	Metformin Hcl	320	99
Albuterol Sulfate Hfa	Albuterol Sulfate	284	94
Hydrochlorothiazide	Hydrochlorothiazide	249	83
Pantoprazole Sodium	Pantoprazole Sodium	217	83
Tamsulosin Hcl	Tamsulosin Hcl	202	59
Potassium Chloride	Potassium Chloride	194	61
Trazodone Hcl	Trazodone Hcl	182	59
Metoprolol Succinate	Metoprolol Succinate	180	55
Duloxetine Hcl	Duloxetine Hcl	178	43
Pradaxa	Dabigatran Etexilate Mesylate	170	56
Furosemide	Furosemide	153	47
Rosuvastatin Calcium	Rosuvastatin Calcium	145	46
Glipizide	Glipizide	141	43
Atenolol	Atenolol	140	45
Pravastatin Sodium	Pravastatin Sodium	138	39
Warfarin Sodium	Warfarin Sodium	118	31
Oxycodone Hcl	Oxycodone Hcl	117	19
Metformin Hcl Er	Metformin Hcl	115	38
Omeprazole	Omeprazole	113	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	113	15
Sertraline Hcl	Sertraline Hcl	109	36
Humulin N	Insulin Nph Human Isophane	104	28
Pregabalin	Pregabalin	102	31
Escitalopram Oxalate	Escitalopram Oxalate	98	33
Clopidogrel	Clopidogrel Bisulfate	97	33
Carvedilol	Carvedilol	95	27
Fluoxetine Hcl	Fluoxetine Hcl	84	29
Donepezil Hcl	Donepezil Hcl	81	28
Terazosin Hcl	Terazosin Hcl	81	20
Meloxicam	Meloxicam	80	28
Buspirone Hcl	Buspirone Hcl	79	24
Alendronate Sodium	Alendronate Sodium	78	25
Tramadol Hcl	Tramadol Hcl	72	18
Spironolactone	Spironolactone	71	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	19
Quetiapine Fumarate	Quetiapine Fumarate	64	12
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	63	14
Finasteride	Finasteride	62	14
Allopurinol	Allopurinol	61	19
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	60	16
Montelukast Sodium	Montelukast Sodium	60	18
Ozempic	Semaglutide	60	suppressed
Ondansetron Odt	Ondansetron	59	24
Triamcinolone Acetonide	Triamcinolone Acetonide	59	37
Alvesco	Ciclesonide	58	19
Citalopram Hbr	Citalopram Hydrobromide	58	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	57	19
Humulin R	Insulin Regular, Human	53	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	16
Jardiance	Empagliflozin	53	15
Tizanidine Hcl	Tizanidine Hcl	52	12
Lorazepam	Lorazepam	51	17
Nystatin	Nystatin	51	27
Lovastatin	Lovastatin	49	15
Wixela Inhub	Fluticasone Propion/Salmeterol	49	17
Prednisone	Prednisone	48	29
Spiriva Respimat	Tiotropium Bromide	48	19
Venlafaxine Hcl Er	Venlafaxine Hcl	48	15
Bupropion Xl	Bupropion Hcl	47	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	15
Ropinirole Hcl	Ropinirole Hcl	45	12
Methocarbamol	Methocarbamol	41	suppressed
Mirtazapine	Mirtazapine	39	16
Bupropion Hcl Sr	Bupropion Hcl	36	14
Ibuprofen	Ibuprofen	36	suppressed
Memantine Hcl	Memantine Hcl	36	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Acyclovir	Acyclovir	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Propranolol Hcl	Propranolol Hcl	32	13
Estradiol	Estradiol	31	17
Fluticasone Propionate	Fluticasone Propionate	31	11
Hydrocortisone	Hydrocortisone	31	15
Doxycycline Monohydrate	Doxycycline Monohydrate	29	23
Shingrix	Varicella-Zoster Ge/As01b/Pf	28	28
Alprazolam	Alprazolam	26	suppressed
Cephalexin	Cephalexin	26	15
Famotidine	Famotidine	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	25	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	25	suppressed
Divalproex Sodium	Divalproex Sodium	24	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	24	suppressed
Lactulose	Lactulose	24	suppressed
Risperidone	Risperidone	24	suppressed
Trospium Chloride	Trospium Chloride	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Digoxin	Digoxin	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	17
Topiramate	Topiramate	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Baclofen	Baclofen	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Naproxen	Naproxen	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	21	21
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Nitroglycerin	Nitroglycerin	18	13
Cefadroxil	Cefadroxil	17	16
Levetiracetam	Levetiracetam	17	suppressed
Naloxone Hcl	Naloxone Hcl	17	14
Prochlorperazine Maleate	Prochlorperazine Maleate	17	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Mupirocin	Mupirocin	16	11
Aripiprazole	Aripiprazole	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Metronidazole	Metronidazole	15	suppressed
Naratriptan Hcl	Naratriptan Hcl	15	suppressed
Torsemide	Torsemide	15	suppressed
Cartia Xt	Diltiazem Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Oxazepam	Oxazepam	14	suppressed
Glipizide Er	Glipizide	13	suppressed
Primidone	Primidone	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error